Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harold Lehman who wrote (803)	1/24/1998 9:14:00 PM
From: Harold Engstrom	Read Replies (2) of 1501

HL, I am not making claims. I don't know whether Merck will choose to use oral or inhaled method of delivering VLA-4 or whether Biogen granted them the license to try both ways. However, there is no reason that if you can deliver the drug orally for the MS indication you can't deliver it orally for Asthma as well. And, I haven't hedged my bets by buying Inflazyme. Actually, I just did a search for news on SI looking for Biogen and found a posting from you on this thread. I hope Inflazyme does really well for your sake and for the sake of others who have invested in this company. Of course, I am an investor in Biogen and hope their drugs also do very well. Over time Biogen's IR department has shown themselves to be very willing to answer questions. No doubt they would answer you as best they can. But, they probably won't give you more details than have already been released. And, for the pursposes of finding out more about VLA-4 trials, Merck might be a better avenue to find information in. I don't think the sheep trials were conducted with inhaled VLA-4, but they might have been. I hope VLA-4 does well, but I didn't buy Biogen for that reason.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next